{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T19:04:38Z","timestamp":1771527878601,"version":"3.50.1"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Pharmetheus AB"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Pharmacokinet Pharmacodyn"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s10928-025-10012-9","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T11:35:21Z","timestamp":1767699321000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Risks encountered when not adjusting for diurnal variation and food effect in QTcF analysis based on phase I data"],"prefix":"10.1007","volume":"53","author":[{"given":"Maddlie","family":"Bardol","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Henrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Celine","family":"Sarr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrica","family":"Mezzalana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jurgen","family":"Langenhorst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,5]]},"reference":[{"key":"10012_CR1","unstructured":"ICH E14 Guideline (2005) The clinical evaluation of QT\/QTC interval prolongation and proarrhythmic potential for nonantiarrhythmic drugs. https:\/\/database.ich.org\/sites\/default\/files\/E14_Guideline.pdf"},{"key":"10012_CR2","doi-asserted-by":"publisher","DOI":"10.1007\/s10928-017-9558-5","author":"C Garnett","year":"2018","unstructured":"Garnett C, Bonate PL, Dang Q, Ferber G, Huang D, Liu J, Mehrotra D, Riley S, Sager P, Tornoe C, Wang Y (2018) Scientific white paper on concentration-QTc modeling. J Pharmacokinet Pharmacodyn. https:\/\/doi.org\/10.1007\/s10928-017-9558-5","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"10012_CR3","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.933","author":"B Cirincione","year":"2017","unstructured":"Cirincione B, Sager PT, Mager DE (2017) Influence of meals and glycemic changes on QT interval dynamics. J Clin Pharmacol. https:\/\/doi.org\/10.1002\/jcph.933","journal-title":"J Clin Pharmacol"},{"key":"10012_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jelectrocard.2015.01.006","author":"K Hnatkova","year":"2015","unstructured":"Hnatkova K, Kowalski D, Keirns JJ, van Gelderen EM, Malik M (2015) Reproducibility of QTc interval changes after meal intake. J Electrocardiol. https:\/\/doi.org\/10.1016\/j.jelectrocard.2015.01.006","journal-title":"J Electrocardiol"},{"key":"10012_CR5","doi-asserted-by":"publisher","DOI":"10.1177\/0091270011419851","author":"J Taubel","year":"2012","unstructured":"Taubel J, Wong AH, Naseem A, Ferber G, Camm AJ (2012) Shortening of the QT interval after food can be used to demonstrate assay sensitivity in thorough QT studies. J Clin Pharmacol. https:\/\/doi.org\/10.1177\/0091270011419851","journal-title":"J Clin Pharmacol"},{"key":"10012_CR6","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.804","author":"MF Mohamed","year":"2017","unstructured":"Mohamed MF, Zeng J, Jiang P, Hosmane B, Othman AA (2017) Use of early clinical trial data to support thorough QT study waiver for Upadacitinib and utility of food effect to demonstrate ECG assay sensitivity. Clin Pharmacol Ther. https:\/\/doi.org\/10.1002\/cpt.804","journal-title":"Clin Pharmacol Ther"},{"key":"10012_CR7","doi-asserted-by":"publisher","DOI":"10.1111\/cts.12640","author":"M Minocha","year":"2019","unstructured":"Minocha M, Li H, Chiu YL, Carter D, Othman AA (2019) Models of variability and circadian rhythm in heart rate, blood pressure, and QT interval for healthy subjects who received placebo in phase I trials. Clin Transl Sci. https:\/\/doi.org\/10.1111\/cts.12640","journal-title":"Clin Transl Sci"},{"key":"10012_CR8","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.975","author":"G Ferber","year":"2018","unstructured":"Ferber G, Fernandes S, T\u00e4ubel J (2018) Estimation of the power of the food effect on QTc to show assay sensitivity. J Clin Pharmacol. https:\/\/doi.org\/10.1002\/jcph.975","journal-title":"J Clin Pharmacol"},{"key":"10012_CR9","doi-asserted-by":"crossref","unstructured":"Darpo B, Garnett C (2013) Early QT assessment\u2013how can our confidence in the data be improved? Br J Clin Pharmacol. doi: 10.1111\/bcp.","DOI":"10.1111\/bcp.12068"},{"key":"10012_CR10","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.2596","author":"C Meyer","year":"2023","unstructured":"Meyer C, Dierick I, Gauderat G, Langenhorst J, Sarr C, Leroux E, Chenel M, Fouliard S, Passier P (2023) How to successfully generate an alternative approach to a thorough QT study: GLPG1972 as an example. Clin Pharmacol Ther. https:\/\/doi.org\/10.1002\/cpt.2596","journal-title":"Clin Pharmacol Ther"},{"key":"10012_CR11","doi-asserted-by":"publisher","DOI":"10.2147\/DHPS.S133286","author":"J Grenier","year":"2018","unstructured":"Grenier J, Paglialunga S, Morimoto BH, Lester RM (2018) Evaluating cardiac risk: exposure response analysis in early clinical drug development. Drug Healthc Patient Saf. https:\/\/doi.org\/10.2147\/DHPS.S133286","journal-title":"Drug Healthc Patient Saf"}],"container-title":["Journal of Pharmacokinetics and Pharmacodynamics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10928-025-10012-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10928-025-10012-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10928-025-10012-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T18:02:53Z","timestamp":1771524173000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10928-025-10012-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,5]]},"references-count":11,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["10012"],"URL":"https:\/\/doi.org\/10.1007\/s10928-025-10012-9","relation":{},"ISSN":["1567-567X","1573-8744"],"issn-type":[{"value":"1567-567X","type":"print"},{"value":"1573-8744","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,5]]},"assertion":[{"value":"25 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaratios"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6"}}